Author Description

This book is divided into five sections and ten chapters, highlighting recent advances in Aspergillus and aspergillosis from pathogenicity to novel diagnosis based on biosensors and metagenomic next-generation sequencing, mechanisms of antifungal drug resistance, Aspergillus–human interactions, immunopathogenesis of invasive aspergillosis, post-viral aspergillosis, treatment strategies, and the importance of beneficial and harmful metabolites of Aspergillusin public health and industry. This book presents cutting-edge research on Aspergillus along with useful information for mycologists, microbiologists, toxicologists, plant pathologists, and pharmacologists who may be interested in understanding the impact, significance, and recent advances within the genus Aspergillus that have not been critically noticed elsewhere.